SMTL ID : 9gk6.1

ERAP1 in complex with 1-[2-(6-chloro-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-4-yl)acetamido]cyclohexane-1-carboxylic acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.33 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.353, H.357, E.376, Y.438 Ligands: MLT.2 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.353, A:H.357, A:E.376, A:E.376

2 x MLT: D-MALATE(Non-covalent)

MLT.2: 11 residues within 4Å: Chain A: S.316, G.317, A.318, E.320, H.353, E.354, H.357, E.376, Y.438 Ligands: ZN.1, EDO.17 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:G.317, A:A.318, A:Y.438 Water bridges: A:E.354, A:K.380 Salt bridges: A:H.353, A:H.357 MLT.3: 6 residues within 4Å: Chain A: L.66, H.68, W.77, G.78, T.79, R.208 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:W.77 Water bridges: A:H.68, A:T.79, A:R.208 Salt bridges: A:H.68, A:R.208

16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.4: 7 residues within 4Å: Chain A: S.340, A.341, S.342, R.700, M.701, S.704, D.741 Ligand excluded by PLIP EDO.5: 5 residues within 4Å: Chain A: E.129, T.185, P.426, R.430, E.840 Ligand excluded by PLIP EDO.6: 3 residues within 4Å: Chain A: K.170, P.273, D.274 Ligand excluded by PLIP EDO.7: 6 residues within 4Å: Chain A: Q.181, S.316, A.318, M.319 Ligands: EDO.8, EDO.17 Ligand excluded by PLIP EDO.8: 6 residues within 4Å: Chain A: R.430, F.433, S.843, S.844 Ligands: EDO.7, EDO.17 Ligand excluded by PLIP EDO.9: 7 residues within 4Å: Chain A: F.401, G.402, M.646, F.649, Q.650, N.653 Ligands: EDO.11 Ligand excluded by PLIP EDO.10: 4 residues within 4Å: Chain A: P.657, L.661, N.893, W.896 Ligand excluded by PLIP EDO.11: 5 residues within 4Å: Chain A: F.649, N.653, Q.705 Ligands: EDO.9, 01.20 Ligand excluded by PLIP EDO.12: 4 residues within 4Å: Chain A: R.665, M.897, D.898, F.901 Ligand excluded by PLIP EDO.13: 5 residues within 4Å: Chain A: L.345, M.349, F.384, Y.399, K.403 Ligand excluded by PLIP EDO.14: 4 residues within 4Å: Chain A: Q.705, L.708, F.778 Ligands: 01.20 Ligand excluded by PLIP EDO.15: 5 residues within 4Å: Chain A: T.643, E.644, I.645, S.698, L.702 Ligand excluded by PLIP EDO.16: 3 residues within 4Å: Chain A: V.712, Q.752, R.782 Ligand excluded by PLIP EDO.17: 6 residues within 4Å: Chain A: S.316, F.433, Y.438 Ligands: MLT.2, EDO.7, EDO.8 Ligand excluded by PLIP EDO.18: 4 residues within 4Å: Chain A: E.157, K.164, D.313, K.838 Ligand excluded by PLIP EDO.19: 8 residues within 4Å: Chain A: H.417, T.421, P.422, V.423, Q.428, E.431, M.432, R.881 Ligand excluded by PLIP

1 x 01: 1-[2-(6-chloranyl-3-oxidanylidene-1,4-benzothiazin-4-yl)ethanoylamino]cyclohexane-1-carboxylic acid

01.20: 14 residues within 4Å: Chain A: N.653, I.656, P.657, Y.659, K.660, Q.705, L.708, L.709, F.778, R.782, R.816, Q.856 Ligands: EDO.11, EDO.14 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.656, A:L.708, A:L.708, A:L.709, A:F.778 Hydrogen bonds: A:K.660, A:Q.856 Water bridges: A:R.782, A:R.782, A:R.782, A:R.782 Salt bridges: A:K.660, A:R.782

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hryczanek, R.P. et al., Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design. Acs Med.Chem.Lett. (2024)

Release Date

2025-01-22

Peptides

Endoplasmic reticulum aminopeptidase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Endoplasmic reticulum aminopeptidase 1

Related Entries With Identical Sequence